Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction.

Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y, Sakakibara M, Yoshimoto T, Guo J, Yamashima T.

Neurosci Res. 2006 Oct;56(2):159-64. Epub 2006 Aug 14.

PMID:
16905216
3.

Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials.

Hoffman DR, Boettcher JA, Diersen-Schade DA.

Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):151-8. doi: 10.1016/j.plefa.2009.05.003. Epub 2009 Jun 7. Review.

PMID:
19505812
4.

Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline.

Yurko-Mauro K.

Curr Alzheimer Res. 2010 May;7(3):190-6. Review.

PMID:
20088810
5.

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J.

Arch Neurol. 2006 Oct;63(10):1402-8.

PMID:
17030655
6.

Rates of decline distinguish Alzheimer's disease and mild cognitive impairment relative to normal aging: integrating cognition and brain function.

Liddell BJ, Paul RH, Arns M, Gordon N, Kukla M, Rowe D, Cooper N, Moyle J, Williams LM.

J Integr Neurosci. 2007 Mar;6(1):141-74.

PMID:
17472227
7.

Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.

Egerházi A, Berecz R, Bartók E, Degrell I.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):746-51. Epub 2007 Jan 16.

PMID:
17289240
8.

Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid.

Henriksen C, Haugholt K, Lindgren M, Aurvåg AK, Rønnestad A, Grønn M, Solberg R, Moen A, Nakstad B, Berge RK, Smith L, Iversen PO, Drevon CA.

Pediatrics. 2008 Jun;121(6):1137-45. doi: 10.1542/peds.2007-1511.

PMID:
18519483
9.

Effects of arachidonate-enriched triacylglycerol supplementation on serum fatty acids and platelet aggregation in healthy male subjects with a fish diet.

Kusumoto A, Ishikura Y, Kawashima H, Kiso Y, Takai S, Miyazaki M.

Br J Nutr. 2007 Sep;98(3):626-35. Epub 2007 Apr 20.

PMID:
17445350
10.

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.

Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS.

JAMA. 2010 Nov 3;304(17):1903-11. doi: 10.1001/jama.2010.1510.

11.

Resting EEG sources correlate with attentional span in mild cognitive impairment and Alzheimer's disease.

Babiloni C, Cassetta E, Binetti G, Tombini M, Del Percio C, Ferreri F, Ferri R, Frisoni G, Lanuzza B, Nobili F, Parisi L, Rodriguez G, Frigerio L, Gurzì M, Prestia A, Vernieri F, Eusebi F, Rossini PM.

Eur J Neurosci. 2007 Jun;25(12):3742-57.

PMID:
17610594
12.

A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.

Arendash GW, Jensen MT, Salem N Jr, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H.

Neuroscience. 2007 Oct 26;149(2):286-302. Epub 2007 Aug 14.

PMID:
17904756
13.

Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.

Lloyd-Still JD, Powers CA, Hoffman DR, Boyd-Trull K, Lester LA, Benisek DC, Arterburn LM.

Nutrition. 2006 Jan;22(1):36-46. Epub 2005 Oct 12.

PMID:
16226012
14.

Fatty aspirin: a new perspective in the prevention of dementia of Alzheimer's type?

Pomponi M, Di Gioia A, Bria P, Pomponi MF.

Curr Alzheimer Res. 2008 Oct;5(5):422-31.

PMID:
18855583
15.

The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population.

Stough C, Downey L, Silber B, Lloyd J, Kure C, Wesnes K, Camfield D.

Neurobiol Aging. 2012 Apr;33(4):824.e1-3. doi: 10.1016/j.neurobiolaging.2011.03.019. Epub 2011 May 4.

PMID:
21531481
16.

Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.

Song IU, Kim JS, Yoo JY, Song HJ, Lee KS.

Eur Neurol. 2008;59(1-2):49-54. Epub 2007 Oct 4.

PMID:
17917458
17.

Arachidonic acid/docosahexaenoic acid-supplemented diet in early life reduces body weight gain, plasma lipids, and adiposity in later life in ApoE*3Leiden mice.

Wielinga PY, Harthoorn LF, Verschuren L, Schoemaker MH, Jouni ZE, van Tol EA, Kleemann R, Kooistra T.

Mol Nutr Food Res. 2012 Jul;56(7):1081-9. doi: 10.1002/mnfr.201100762. Epub 2012 May 18.

PMID:
22611002
18.

Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.

Reed BR, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C, Jagust WJ, Chui HC.

Brain. 2007 Mar;130(Pt 3):731-9. Epub 2007 Jan 31.

PMID:
17267522
19.

The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.

Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, Stewart R, Huang SY.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1538-44. doi: 10.1016/j.pnpbp.2008.05.015. Epub 2008 May 25.

PMID:
18573585
20.

Arachidonic acid supplementation decreases P300 latency and increases P300 amplitude of event-related potentials in healthy elderly men.

Ishikura Y, Ikeda G, Akimoto K, Hata M, Kusumoto A, Kidokoro A, Kontani M, Kawashima H, Kiso Y, Koga Y.

Neuropsychobiology. 2009;60(2):73-9. doi: 10.1159/000236447. Epub 2009 Sep 10.

PMID:
19752581

Supplemental Content

Support Center